PR-295: Pharmacy Direct/Indirect Remuneration (DIR) Adjustment
PR-295: The patient is financially responsible for this amount. Verify the determination is correct before initiating patient billing.
What Does PR-295 Mean?
When paired with Group Code PR, CARC 295 shifts the financial responsibility to the patient. The adjustment for pharmacy direct/indirect remuneration (dir) adjustment is deemed the patient's responsibility. The provider should verify the PR designation is correct before billing the patient.
CARC 295 is a pharmacy-specific adjustment code used to communicate Direct and Indirect Remuneration (DIR) fees and adjustments on a remittance advice. DIR refers to additional compensation or fee recoupments that occur after the initial point-of-sale claim payment. These adjustments modify the final effective reimbursement the pharmacy receives for a dispensed drug.
DIR fees became a significant issue in Medicare Part D, where plan sponsors and PBMs assess retroactive fees to pharmacies based on various factors including performance metrics, network participation fees, and quality measures. These fees are typically assessed months after the initial claim payment, creating cash flow challenges for pharmacies. A pharmacy may receive the full contracted amount at the point of sale, only to have a portion clawed back later as a DIR adjustment reported through CARC 295.
The DIR landscape has undergone regulatory changes, with CMS implementing reforms to move DIR fees to the point of sale rather than retroactive assessment. However, CARC 295 continues to appear on remittance advices for pharmacy claims. Pharmacies should carefully track these adjustments against their PBM contracts to ensure the amounts are consistent with agreed-upon fee schedules and performance benchmarks.
How to Resolve
- Verify patient responsibility Confirm that the PR group code assignment is correct for the CARC 295 adjustment. Review the remittance advice and any RARC codes for context.
- Review for potential errors Check whether the underlying denial reason can be corrected, which may eliminate the patient's responsibility. Verify coding accuracy and documentation completeness.
- Appeal if designation is incorrect If the PR assignment appears incorrect or the denial is in error, file an appeal with supporting documentation before billing the patient.
- Generate patient statement If the determination is correct, generate a patient statement for the amount and follow standard patient collection procedures.
- Communicate with the patient Explain the charge to the patient, provide information about their financial responsibility, and discuss payment options.
Pharmacy Direct/Indirect Remuneration (DIR) Adjustment grouped under PR places the financial responsibility on the patient. The specific reason depends on the context of this adjustment — review any accompanying RARC codes for detail. Because this represents a placement of responsibility rather than a coverage denial, an appeal isn't the right action; verify the placement is correct before billing the patient.
How to Prevent PR-295
- Verify patient coverage and financial responsibility before rendering services
- Communicate potential out-of-pocket costs to patients proactively
- Review PR-295 adjustments before billing to confirm the designation is appropriate
Also Filed As
The same CARC 295 may appear with different Group Codes:
Related Denial Codes
Sources
- https://www.mdclarity.com/denial-code/295
- https://resdac.org/sites/datadocumentation.resdac.org/files/Adjustment%20Reason%20Code%20Code%20Table%20(TAF%20Claims).txt
- https://x12.org/codes/claim-adjustment-reason-codes
- Codes maintained by X12. Visit x12.org for official definitions.